BACKGROUND: This study evaluates the effects of retinol on intestinal barrier function, growth, total parasites, and Giardia spp infections in children in northeastern Brazil. SUBJECTS AND METHODS: The study was a double-blind, randomized placebo-controlled trial (http://clinicaltrials.gov; register no. #NCT00133406) involving 79 children who received vitamin A 100,000-200,000 IU (n = 39) orplacebo (n = 40) at enrollment, 4, and 8 months and were followed for 36 months. Intestinal barrier function was evaluated using the lactulose:mannitol ratio test. Stool lactoferrin was used as a marker for intestinal inflammation. RESULTS: The groups were similar with regard to age, sex, nutritional parameters (z scores), serum retinol concentrations, proportion of lactoferrin-positive stool samples, and intestinal barrier function. The lactulose:mannitol ratio did not change during the same time of follow-up (P > 0.05). The proportion of lactoferrin-positive samples evaluated at 1 month did not change between groups (P > 0.05). Total intestinal parasitic, specifically new, infections were significantly lower in the vitamin A treatment compared with control group; these were accounted for entirely by significantly fewer new Giardia infections in the vitamin A treatment group. The cumulative z scores for weight-for-length or height, length or height-for-age z scores, and weight-for-age did not change significantly with vitamin A intervention for 36 months of follow-up. CONCLUSIONS: These data showed that total parasitic infection and Giardia spp infections were significantly lower in the vitamin A treatment group when compared with the placebo group, suggesting that vitamin A improves the host's defenses against Giardia infections.
RCT Entities:
BACKGROUND: This study evaluates the effects of retinol on intestinal barrier function, growth, total parasites, and Giardia spp infections in children in northeastern Brazil. SUBJECTS AND METHODS: The study was a double-blind, randomized placebo-controlled trial (http://clinicaltrials.gov; register no. #NCT00133406) involving 79 children who received vitamin A 100,000-200,000 IU (n = 39) or placebo (n = 40) at enrollment, 4, and 8 months and were followed for 36 months. Intestinal barrier function was evaluated using the lactulose:mannitol ratio test. Stool lactoferrin was used as a marker for intestinal inflammation. RESULTS: The groups were similar with regard to age, sex, nutritional parameters (z scores), serum retinol concentrations, proportion of lactoferrin-positive stool samples, and intestinal barrier function. The lactulose:mannitol ratio did not change during the same time of follow-up (P > 0.05). The proportion of lactoferrin-positive samples evaluated at 1 month did not change between groups (P > 0.05). Total intestinal parasitic, specifically new, infections were significantly lower in the vitamin A treatment compared with control group; these were accounted for entirely by significantly fewer new Giardia infections in the vitamin A treatment group. The cumulative z scores for weight-for-length or height, length or height-for-age z scores, and weight-for-age did not change significantly with vitamin A intervention for 36 months of follow-up. CONCLUSIONS: These data showed that total parasitic infection and Giardia spp infections were significantly lower in the vitamin A treatment group when compared with the placebo group, suggesting that vitamin A improves the host's defenses against Giardia infections.
Authors: J L Mills; J Tuomilehto; K F Yu; N Colman; W S Blaner; P Koskela; W E Rundle; M Forman; L Toivanen; G G Rhoads Journal: J Pediatr Date: 1992-06 Impact factor: 4.406
Authors: Kurt Z Long; Jose Ignacio Santos; Jorge L Rosado; Catalina Lopez-Saucedo; Rocio Thompson-Bonilla; Maricela Abonce; Herbert L DuPont; Ellen Hertzmark; Teresa Estrada-Garcia Journal: J Infect Dis Date: 2006-09-26 Impact factor: 5.226
Authors: Kurt Z Long; Jose Ignacio Santos; Teresa Estrada Garcia; Meredith Haas; Mathew Firestone; Jui Bhagwat; Herbert L Dupont; Ellen Hertzmark; Jorge L Rosado; Nanda N Nanthakumar Journal: J Nutr Date: 2006-10 Impact factor: 4.798
Authors: C A Redlich; J N Grauer; A M Van Bennekum; S L Clever; R B Ponn; W S Blaner Journal: Am J Respir Crit Care Med Date: 1996-11 Impact factor: 21.405
Authors: Daniel J Raiten; Fayrouz A Sakr Ashour; A Catharine Ross; Simin N Meydani; Harry D Dawson; Charles B Stephensen; Bernard J Brabin; Parminder S Suchdev; Ben van Ommen Journal: J Nutr Date: 2015-04-01 Impact factor: 4.798
Authors: Dana T Lounder; Pooja Khandelwal; Christopher E Dandoy; Sonata Jodele; Michael S Grimley; Gregory Wallace; Adam Lane; Cynthia Taggart; Ashley C Teusink-Cross; Kelly E Lake; Stella M Davies Journal: Blood Date: 2017-03-09 Impact factor: 22.113
Authors: Priscilla M Ueno; Reinaldo B Oriá; Elizabeth A Maier; Marjorie Guedes; Orleancio G de Azevedo; David Wu; Tara Willson; Simon P Hogan; Aldo A M Lima; Richard L Guerrant; D Brent Polk; Lee A Denson; Sean R Moore Journal: Am J Physiol Gastrointest Liver Physiol Date: 2011-07-28 Impact factor: 4.052
Authors: Mark D DeBoer; Aldo A M Lima; Reinaldo B Oría; Rebecca J Scharf; Sean R Moore; Max A Luna; Richard L Guerrant Journal: Nutr Rev Date: 2012-11 Impact factor: 7.110